Navigation Links
Spherix Announces Third Quarter Financial Results
Date:11/11/2011

biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides.  For more information, please visit www.spherix.com.

Forward-Looking Statements This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934.  Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission.  Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this rel
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds
2. Spherix to Raise $1.25 Million in Private Placement
3. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
4. Spherix Announces Annual Shareholders Meeting Date
5. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
6. Spherix Regains Compliance With NASDAQ Listing Rule
7. Spherix Announces First Quarter Financial Results
8. Spherix Announces Reverse Stock Split Effective May 6, 2011
9. Spherix to Effect Reverse Stock Split
10. Spherix Announces 2010 Financial Results
11. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... NEWTOWN, Pa. , June 2, 2015   ... services and technology provider, today announced that David ... has been named Executive Vice President and Chief Financial ... 8, 2015. Peters brings more than 25 ... in pharmaceutical services. "David has extensive and deep knowledge ...
(Date:6/2/2015)... 2, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that Dr. Pamela Pavco , ... the 23 rd World Congress of ... include in-depth presentations by world-class clinicians and/or ...
(Date:6/2/2015)... , June 2, 2015 GOJO, inventors of ... commitment to antibiotic stewardship at the White House Forum.  ... animal health organizations and stakeholders at the White House ... to slow the emergence of antibiotic-resistant bacteria, detect resistant ... prevent the spread of resistant infections. "A ...
(Date:6/2/2015)... German-based Moenninghoff has designated the R.M. Hoffman Company ... Moenninghoff product line . , Moenninghoff President ... the R.M. Hoffman Company will be representing Moenninghoff in ... this is a strategically important step. We are ... distributor we need to successfully grow our business in ...
Breaking Biology Technology:BioClinica Names David Peters New Chief Financial Officer 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3
... more hopeful promises of stem cells is the creation of new ... met by organ donation. But experts expressed concerns at last week's ... patients if cures do not materialize, and among investors if nobody ... way that stem cells could be used in the medical and ...
... A key lawmaker who often disagrees with Governor Jim ... saw nothing inappropriate about the governor's use of an executive ... cell companies. , ,Meanwhile, the executive order, signed Tuesday at ... the director of Pro Life Wisconsin. , ,Ted Kanavas, R-Brookfield, ...
... GE Healthcare has received federal approval for ... imaging for the estimated 20% of Americans that are considered ... from the Food and Drug Administration for its new wide ... therapy. The system is designed to meet growing demand for ...
Cached Biology Technology:Stem cells raise hopes, but is there money in them? 2Stem cells raise hopes, but is there money in them? 3Republican sees nothing wrong with Doyle's use of executive order 2FDA okays new GE tomography system 2
(Date:5/10/2015)... 11, 2015 Fingerprint Cards (FPC) has ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... by smartphone manufacturers in China . The ... revenue guidance of + 1 000 MSEK for 2015.   ...
(Date:5/6/2015)... May 6, 2015 LifeBEAM, a developer of ... producer, announced today that they will expand their partnership ... first bio-sensing cycling helmet and the first joint project ... new colors in order to give cyclists more style ... addition, LifeBEAM and Lazer announced their plan to release ...
(Date:4/27/2015)... Conn. , Apr. 27, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... commence shipping to pre-order customers the first week of ... through the month of May. ... a significant milestone for the company as Wocket® enters ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... winner of the 2007 Ebbe Nielsen Prize in biodiversity ... 2007 Ebbe Nielsen Prize has been awarded to Paul ... Information Facility (GBIF) established the Prize in honor of ... in the fields of biosystematics and biodiversity informatics. This ...
... David Schmale prepares plane to collect Fusarium samples. ... autonomous unmanned aerial vehicles (UAVs) to detect airborne ... assistant professor of plant pathology, physiology, and weed ... Sciences, has not only linked agriculture and engineering ...
... chimpanzees’ cognitive abilities, according to new research from the ... The study (1) is the first to demonstrate that ... cognitive abilities, as measured by their ability to understand ... published online in the Springer journal Animal Cognition. , ...
Cached Biology News:Australian wins prestigious prize in biodiversity informatics 2Small, self-controlled planes combine plant pathology and engineering 2Small, self-controlled planes combine plant pathology and engineering 3Nurtured chimps rake it in 2
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
p38 MAP Kinase gamma Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
...
Biology Products: